Summit Securities Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3K Sell
133
-1,063
-89% -$94.7K ﹤0.01% 645
2025
Q4
$94.5K Sell
1,196
-1,835
-61% -$144K 0.01% 478
2025
Q3
$242K Buy
3,031
+2,486
+456% +$212K 0.05% 247
2025
Q2
$49.5K Sell
545
-902
-62% -$82.3K 0.01% 519
2025
Q1
$136K Buy
+1,447
New +$130K 0.02% 206
2023
Q3
Sell
-1,085
Closed -$84K 636
2023
Q2
$84K Sell
1,085
-554
-34% -$42.9K 0.01% 313
2023
Q1
$123K Sell
1,639
-3,608
-69% -$268K 0.01% 267
2022
Q4
$413K Sell
5,247
-341
-6% -$25.6K 0.02% 268
2022
Q3
$393K Buy
5,588
+3,038
+119% +$238K 0.03% 291
2022
Q2
$204K Buy
2,550
+1,405
+123% +$110K 0.03% 298
2022
Q1
$87K Buy
+1,145
New +$90.7K 0.01% 533
2016
Q1
Sell
-5,672
Closed -$378K 172
2015
Q4
$378K Buy
5,672
+5,072
+845% +$337K 0.12% 121
2015
Q3
$38K Buy
+600
New +$39.2K 0.03% 178
2015
Q1
Sell
-2,700
Closed -$187K 414
2014
Q4
$187K Sell
2,700
-300
-10% -$20.3K 0.05% 200
2014
Q3
$196K Buy
3,000
+2,000
+200% +$132K 0.06% 216
2014
Q2
$68K Buy
+1,000
New +$67K 0.02% 272
2014
Q1
Sell
-66,600
Closed -$4.34M 427
2013
Q4
$4.34M Sell
66,600
-22,200
-25% -$1.42M 0.76% 26
2013
Q3
$5.27M Buy
88,800
+56,800
+178% +$3.37M 1.79% 12
2013
Q2
$1.83M Buy
+32,000
New +$1.9M 0.88% 25

Other funds holding CL

Summit Securities Group's CL Position: Q1 2026 in Review

Summit Securities Group reduced its Colgate-Palmolive (CL) stake by 89% in Q1 2026, selling an estimated $94.7K and leaving 133 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Summit Securities Group first reported a position in CL in Q2 2013 and has held it in 19 quarters since. The position peaked at $5.27M in Q3 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Summit Securities Group held 133 shares of Colgate-Palmolive worth $11.3K as of Q1 2026.
  • Summit Securities Group sold 1,063 Colgate-Palmolive shares in Q1 2026, an estimated $94.7K.
  • Colgate-Palmolive made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #645 holding.
  • Summit Securities Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 19 quarters since.
  • Summit Securities Group's Colgate-Palmolive position peaked at $5.27M in Q3 2013.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.